Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
36 GBX
Updated:
May 1, 2024
Creo Medical Group PLC
Cash from Financing Activities
|
Creo Medical Group PLC
Cash from Financing Activities Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
AGL
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Creo Medical Group PLC
LSE:CREO
|
Cash from Financing Activities
£522k
|
CAGR 3-Years
-78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Cash from Financing Activities
-$200m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Cash from Financing Activities
$21.5m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Cash from Financing Activities
$165.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Cash from Financing Activities
-£3.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-9%
|
|
|
Angle PLC
LSE:AGL
|
Cash from Financing Activities
£17.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Cash from Financing Activities?
Cash from Financing Activities
522k
GBP
522k
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Cash from Financing Activities amounts to 522k GBP.
What is Creo Medical Group PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-78%
-78%
Over the last year, the Cash from Financing Activities growth was -98%. The average annual Cash from Financing Activities growth rates for Creo Medical Group PLC have been -78% over the past three years .
You don't have any saved screeners yet
